In relation to Pharmac—I appreciate I'm running short of time in this particular slot. Again, I know Pharmac is working with others through additional either indications for existing treatments that they fund or procuring new treatments. They are working very closely, I know, with the Cancer Control Agency on all of those things, new indications and whole new treatments. So again, even at this point, it's not possible to say exactly what the number will be. I imagine that will become clearer in the next sort of two to three months. I met with Pharmac yesterday to ask for progress on how that is going. They said they're kind of at the final stages of making some decisions about that, so we'll kind of see how that goes in that respect.